Slovenian Genialis raises $13M to improve diseases treatment with AI and ML
Genialis, a medtech company, has raised $13 million in Series A funding  to transform the way diseases are diagnosed and treatment decisions are made. Taiwania Capital and Debiopharm Innovation Fund co-led the round. “Genialis has an impressively clear vision, compelling